Next, we demonstrated that APS significantly upregulated the HIF‐1 signalling pathway, and HIF‐1α inhibitor destroyed the radioprotection of APS by using network pharmacology, RNA‐seq and small inhibitor. The gene discussed is HIF1A; the disease is autoimmune polyendocrinopathy.